In this multicenter , randomized , double-blind , placebo-controlled study , we assessed larazotide acetate @ , @ , or @ mg @ times daily to relieve ongoing symptoms in @ adults with CeD who had been on a GFD for @ months or longer and maintained their current GFD during the study .